ArticleHealthcare (Basel, Switzerland)2025
Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study.
Yazed AlRuthia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.